LINDSAY WAHLSTROM: Open Payments
NPI 1598148108 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,077 in 62 payments from 13 companies in 2025. Trend: 2023 $21 · 2024 $265 · 2025 $1,077
Food & beverage: $1,033Education: $43
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $176 |
| Novo Nordisk Inc | 10 | $173 |
| PFIZER INC. | 11 | $163 |
| AstraZeneca Pharmaceuticals LP | 8 | $149 |
| Amgen Inc. | 11 | $136 |
| ABBVIE INC. | 5 | $109 |
| Phathom Pharmaceuticals, Inc. | 2 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Astellas Pharma US Inc | 1 | $19 |
| SANOFI-AVENTIS U.S. LLC | 1 | $18 |
Products named: MOUNJARO, Ozempic, ELIQUIS, OTEZLA, AIRSUPRA, QULIPTA, JARDIANCE, Wegovy.
Industry payments across KS — which companies pay providers there.
